Amitabh Bachchan falls ill on 'Thugs Of Hindostan' sets in Jodhpur

News Network
March 13, 2018

New Delhi, Mar 13: Megastar Amitabh Bachchan, who has been shooting for Yash Raj Films' 'Thugs Of Hindostan' in Jodhpur has reportedly fallen ill and a team of doctors from Mumbai have rushed to reach him immediately.

In his latest blog, the megastar mentioned about his ill health and how his doctors will soon join him in Jodhpur for a regular check-up. Here's the excerpt from his blog:

“I am getting my team of doctors in tomorrow morning to fiddle around with my body and set me up again .. i will rest and keep informed in process.”

Reports suggest that due to change of weather, the megastar's health has taken a back seat and the unit of 'Thugs Of Hindostan' is worried about the same. The team of doctors was rushed to Jodhpur by a chartered plane. Reportedly, doctors will be reaching Ajit Bhawan shortly.

Team of doctors clicked at the airport.

'Thugs Of Hindostan' is helmed by 'Dhoom 3' director Vijay Acharya Krishna and stars Aamir Khan in the lead role. The film also features Katrina Kaif and Fatima Sana Shaikh besides Bachchan senior in a pivotal part.

This is the first time that Big B and Aamir Khan have joined forces for a project.

Get well soon, Mr Bachchan!

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 23,2020

Jan 23: Calling himself an optimist who believes in the goodness of people, director Kabir Khan says everything these days is being looked at through the prism of religion but India is about more than that.

The director of blockbusters such as Bajrangi Bhaijaan and Ek Tha Tiger said he is happy he has a platform as a filmmaker to present a counterpoint to the prevailing narrative based on religious fault lines.

"I’m an optimist who believes in the goodness of the people. But yes, there is a certain level of bigotry that has crept in. Everything is being looked at through the prism of religion but India is not about that.

"It sounds like a cliché but when I was growing up, I was not aware of my religion. That was the greatness of this country,” Kabir told news agency.

He said he is a product of a mixed marriage and is pained to see the social fabric being tattered.

“I have celebrated the best that Indian secularism has to offer. But to see the greatness of this country being simplified and broken down into religious fault lines is a painful experience,” he added.

According to Kabir, it is dangerous to see history through the prism of religion, whether in cinema or society. But it is important to revisit history to know what happened and one can always find something that is relevant for the present, he said.

The director, who started as a documentary filmmaker, returns to his roots for a five-episode series on Subhas Chandra Bose's Indian National Army, The Forgotten Army: Azaadi Ke Liye, on Amazon Prime, his most expensive project yet.

Asked whether this is a difficult time for filmmakers, Kabir said he believes art thrives in the time of strife and, as a storyteller, his politics will always reflect in his work.

“Every film has its politics and every filmmaker has to reflect his or her politics. Every film of mine will reflect my politics and it will never change according to the popular mood of the audience. But a film should not be just about that. Politics should be in the layers beneath," he said.

He terms his 2015 Salman Khan-starrer Bajrangi Bhaijaan an "extremely political" film. At face value, it can also be enjoyed as the story of a mute Pakistani girl who drifts into India and is taken back to her homeland by a Hanuman devotee. But there is so much more. The "chicken song", for instance, was a sly reference to the beef ban controversy at the time, he said.

"I won’t say it is a difficult time for me as a filmmaker. It is good that I have a platform where I can talk and present a counterpoint and I refuse to believe that the entire country believes the narrative that is being sent out. There are millions and millions of people, and perhaps the majority, that does not believe. And if I present the counterpoint, they will think about it.”

Discussing his new series, the director said it has always fascinated him that the sacrifice of the men and women who comprised the INA is just a forgotten footnote in history.

“I wanted to make something that stands the test of time. It goes down in posterity,” Khan, who first explored the subject in a Doordarshan documentary 20 years ago, said.

For the documentary, he traveled with former INA officers Captain Lakshmi Sahgal and Captain Gurbaksh Singh Dhillon from Singapore to India via erstwhile Burma, retracing the route that the INA followed.

“The documentary got me a lot of attention and acclaim but the story just never left me. It's actually the first script I ever wrote and I landed up with that script in Bombay from Delhi. I realised very soon that nobody's going to give me a budget of this size to make my first film.

"And then after every film, I would pick up the script and say, ‘Okay, this is the one I want to make’, because this is the story that made me want to become a filmmaker. On the way, I ended up making eight other films but this is really the story that I wanted to make,” he said.

Kabir is happy that the story has come out as a series, not a film, as it would have required to compromise with the budget and other elements.

"Without giving any numbers, this is the most expensive project I have ever worked on… It required that kind of budget."

Kabir believes the INA was responsible for bringing down the morale of the British establishment, which realised it would be impossible to keep the country colonised without the support of the local army.

"There are a lot of debates and discussions about what happened with the INA and the controversies around it. The whole point is that, if you want to judge what the Army did, sure that's your prerogative, but at least get to know what they did. Nobody knows what happened with the Army from 1942 to 1945."

He added that 55,000 men and women of the INA fought for independence and 47,000 of them died.

"Not a single person from that Army was ever taken back into the independent Army, which is such an amazing fact... the fact that the British called them traitors became the narrative and we also started assuming that they were traitors."

"They were the only women's regiment in the whole world 70 years ago. That's what they thought about women's importance in society. I don't know whether they will be happy with what the current situation is," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 26,2020

New Delhi, Jul 26: India reported a spike of 48,661 coronavirus cases in the last 24 hours, said the Union Ministry of Health and Family Welfare on Sunday.

The total COVID-19 positive cases stand at 13,85,522, including 4,67,882 active cases, 8,85,577 cured/discharged/migrated, it added.
With 705 deaths in the last 24 hours, the cumulative toll reached 32,063.

Maharashtra has reported 3,66,368 coronavirus cases, the highest among states and Union Territories in the country.

A total of 2,06,737 cases have been reported from Tamil Nadu till now, while Delhi has recorded a total of 1,29,531 coronavirus cases.

According to the Indian Council of Medical Research (ICMR), 4,42,263 samples were tested for coronavirus on Saturday and overall 1,62,91,331 samples have been tested so far.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.